PGEN: Precigen, Inc.
Performance
PGEN +21.28%
Watchlist
Select an item
Summary
PGEN at a glance
PGEN returned +21.28% over the past year and -1.53% a year over five years. Its worst drop in that year was -50.70%, smaller than 22% of stocks on Redstone, and its Sharpe ratio of 0.61 beats 56% of stocks on Redstone. It pays no dividends.
Current Drawdown
-44.74%
Rolling Volatility
123.08%
Actions
Metrics
Risk Indicators
Alpha35.83%
Beta1.61x
Sharpe0.61
Sortino0.92
Omega1.12
Calmar0.42
Martin2.70
Profile
About PGEN
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.7B
- Listed
- Aug 2013
- Employees
- 47
- Headquarters
- Germantown, MD
- Website
- precigen.com
Comparisons